OncoSec Medical OverviewOncoSec Medical EBIT
EBIT (Earnings Before Interest and Taxes) analysis for ONCS.
Quarterly EBIT
-$7.66M
↑ 18.62% YoY
As of Jan 31, 2023
Annual EBIT (TTM)
-$32.65M
↑ 25.19% YoY
Trailing 12 months ending Jan 31, 2023
OncoSec Medical OverviewEBIT (Earnings Before Interest and Taxes) analysis for ONCS.
As of Jan 31, 2023
Trailing 12 months ending Jan 31, 2023